Search
for
Sort by
Research 211–240 of 1000+
- The Genetic Architecture of Alopecia Areata
- Clinical Application of Development of Nonantibiotic Macrolides That Correct Inflammation-Driven Immune Dysfunction in Inflammatory Skin Diseases
- T <sub>H</sub> 1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata
- Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
- The potential of regulatory T cell-based therapies for alopecia areata
- Associations between ionomic profile and metabolic abnormalities in a murine model of sodium sulfide induced alopecia areata
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- Recurrent implantation failure: A comprehensive summary from etiology to treatment
- Birth, life, and death of the MAGE3 hypothesis of alopecia areata pathobiology
- Unusual acute lupus hemophagocytic syndrome – a test of diagnostic criteria: a case report
- Hair follicle-derived melanocyte transplant as a promising treatment strategy for vitiligo
- Alopecia areata: current concepts
- A “hair‐raising” history of alopecia areata
- Hair Follicle-Related MicroRNA-34a Serum Expression and rs2666433A/G Variant in Patients with Alopecia: A Cross-Sectional Analysis
- The Role of Sex and Gender in Dermatology - From Pathogenesis to Clinical Implications
- Cancer risk in patients with alopecia areata: a nationwide population‐based matched cohort study
- Third International Research Workshop on Alopecia Areata
- Th1/Th2 PB balance and CD200 expression of patients with active severe alopecia areata
- Innate immunity and the regulation and mobilization of keratinocyte stem cells: are the old players playing a new game?
- How Our Microbiome Influences the Pathogenesis of Alopecia Areata
- Study of the Thyroid Profile of Patients with Alopecia
- Summary of the Preceding Three Alopecia Areata Research Summits: What’s Past Is Prologue
- Ophthalmologic Comorbidities in Alopecia Areata
- Recent advances in the genetics of alopecia areata
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- The genetics of alopecia areata: New approaches, new findings, new treatments
- Diverse Role of OX40 on T Cells as a Therapeutic Target for Skin Diseases
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- 3D spheroid culture synchronizes heterogeneous MSCs into an immunomodulatory phenotype with enhanced anti-inflammatory effects
- Intranasal sensitization model of alopecia areata using pertussis toxin as adjuvant